Physician profile
Likhitha Reddy
NPI 1124580907
$459.91
in general payments reported to CMS, 2019-2025
11 companies · $90.80 in 2025
The $90.80 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $42.03 · 2023: $117 · 2024: $210 · 2025: $90.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330 · Long Term Medical Supply Or Device Loan: $88.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.55 |
| Long Term Medical Supply Or Device Loan | $88.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $88.33 | 2024 | Hillrom - Spot Vision Screener |
| Sanofi Pasteur INC. | $79.35 | 2022-2024 | |
| Cranial Technologies, INC | $71.65 | 2023-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $46.94 | 2024-2025 | |
| Pfizer INC. | $34.48 | 2022-2024 | |
| Tris Pharma INC | $33.60 | 2025 | Dyanavel Xr, Onyda Xr |
| Astrazeneca Pharmaceuticals LP | $28.10 | 2024 | Flumist Quadrivalent |
| Sobi, INC | $24.24 | 2023 | |
| Merck Sharp & Dohme LLC | $22.63 | 2023 | Proquad, Vaxneuvance, Gardasil 9 |
| Verrica Pharmaceuticals INC. | $15.91 | 2024 | Ycanth |
| Aytu Biopharma, INC. | $14.68 | 2024 | Karbinal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Likhitha Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.